About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Ranking Vaccines Applications of a Prioritization Software ... Released: December 19, 2014
    In the Phase III work, the IOM in partnership with the National Academy of Engineering enhanced SMART Vaccines—version 1.1 of the software can be downloaded for free from www.nap.edu/smartvaccines. The supporting report, Ranking Vaccines: Applications of a Prioritization Software Tool, describes: (1) the evaluation of the software in international user-based applications, (2) a general data framework for the software, and (3) the next steps that would increase the use and value of SMART Vaccines.
  • Ranking Vaccines: A Prioritization Software Tool - Phase II ... Released: September 30, 2013
    In 2012, the IOM released Ranking Vaccines: A Prioritization Framework (Phase I: Demonstration of Concept and a Software Blueprint) which offered a framework and proof of concept for a software prototype called SMART Vaccines to account for various factors influencing vaccine prioritization — demographic, economic, health, scientific, business, programmatic, social, policy factors and public concerns. In this report, Ranking Vaccines: A Prioritization Software Tool (Phase II: Prototype of a Decision-Support System) a functional version of SMART Vaccines 1.0 is discussed and elaborated along with its potential application in making decisions about new vaccine development.
  • Ranking Vaccines: A Prioritization Framework - Phase I ... Released: May 10, 2012
    Ranking Vaccines: A Prioritization Framework describes a decision-support model and the blueprint of a software called Strategic Multi-Attribute Ranking Tool for Vaccines, or SMART Vaccines, that should help decision makers prioritize new vaccines by accounting for demographic, economic, health, scientific, business, programmatic, social, policy and related factors.